1
|
Biological Activity, Lipophilicity and Cytotoxicity of Novel 3-Acetyl-2,5-disubstituted-1,3,4-oxadiazolines. Int J Mol Sci 2021; 22:ijms222413669. [PMID: 34948461 PMCID: PMC8704594 DOI: 10.3390/ijms222413669] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2021] [Revised: 12/10/2021] [Accepted: 12/13/2021] [Indexed: 01/21/2023] Open
Abstract
Antibiotic resistance is now a global problem, and the lack of effective antimicrobial agents for the treatment of diseases caused by resistant microbes is increasing. The 3-acetyl-2,5-disubstituted-1,3,4-oxadiazolines presented in this article may provide a good starting point for the development of potential new effective antimicrobial agents useful in the treatment of bacterial and fungal infections. Particular attention is drawn to the 1,3,4-oxadiazole derivative marked with the number 29 with 5-nitrofuran-2-yl substituent in its chemical structure. This substance showed a strong bactericidal effect, especially against Staphylococcus spp., and no cytotoxicity to the L929 normal cell line.
Collapse
|
2
|
Paruch K, Popiołek Ł, Biernasiuk A, Hordyjewska A, Malm A, Wujec M. Novel 3-Acetyl-2,5-disubstituted-1,3,4-oxadiazolines: Synthesis and Biological Activity. Molecules 2020; 25:E5844. [PMID: 33322054 PMCID: PMC7763531 DOI: 10.3390/molecules25245844] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2020] [Revised: 12/04/2020] [Accepted: 12/06/2020] [Indexed: 12/30/2022] Open
Abstract
The aim of our study was the two-stage synthesis of 1,3,4-oxadiazole derivatives. The first step was the synthesis of hydrazide-hydrazones from 3-methyl-4-nitrobenzhydrazide and the corresponding substituted aromatic aldehydes. Then, the synthesized hydrazide-hydrazones were cyclized with acetic anhydride to obtain new 3-acetyl-2,3-disubstituted-1,3,4-oxadiazolines. All of obtained compounds were tested in in vitro assays to establish their potential antimicrobial activity and cytotoxicity. Our results indicated that few of the newly synthesized compounds had some antimicrobial activity, mainly compounds 20 and 37 towards all used reference bacterial strains (except Klebsiella pneumoniae, Proteus mirabilis, and Pseudomonas aeruginosa) and fungi. These substances showed a strong or powerful bactericidal effect, especially against Staphylococcus spp. belonging to Gram-positive bacteria. Compound 37 was active against Staphylococcus epidermidis at minimal inhibitory concentration (MIC) = 0.48 µg/mL and was characterized by low cytotoxicity. This compound possessed quinolin-4-yl substituent in the second position of 1,3,4-oxadiazole ring and 3-methyl-4-nitrophenyl in position 5. High effectiveness and safety of these derivatives make them promising candidates as antimicrobial agents. Whereas the compound 20 with the 5-iodofurane substituent in position 2 of the 1,3,4-oxadiazole ring showed the greatest activity against S. epidermidis at MIC = 1.95 µg/mL.
Collapse
Affiliation(s)
- Kinga Paruch
- Chair and Department of Organic Chemistry, Faculty of Pharmacy, Medical University of Lublin, 4A Chodźki Street, 20-093 Lublin, Poland; (Ł.P.); (M.W.)
| | - Łukasz Popiołek
- Chair and Department of Organic Chemistry, Faculty of Pharmacy, Medical University of Lublin, 4A Chodźki Street, 20-093 Lublin, Poland; (Ł.P.); (M.W.)
| | - Anna Biernasiuk
- Chair and Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Medical University of Lublin, 1 Chodźki Street, 20-093 Lublin, Poland; (A.B.); (A.M.)
| | - Anna Hordyjewska
- Chair and Department of Medicinal Chemistry, Faculty of Medical Dentistry, Medical University of Lublin, 4A Chodźki Street, 20-093 Lublin, Poland;
| | - Anna Malm
- Chair and Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Medical University of Lublin, 1 Chodźki Street, 20-093 Lublin, Poland; (A.B.); (A.M.)
| | - Monika Wujec
- Chair and Department of Organic Chemistry, Faculty of Pharmacy, Medical University of Lublin, 4A Chodźki Street, 20-093 Lublin, Poland; (Ł.P.); (M.W.)
| |
Collapse
|
3
|
Abdildinova A, Gong YD. Current Parallel Solid-Phase Synthesis of Drug-like Oxadiazole and Thiadiazole Derivatives for Combinatorial Chemistry. ACS COMBINATORIAL SCIENCE 2018; 20:309-329. [PMID: 29714475 DOI: 10.1021/acscombsci.8b00044] [Citation(s) in RCA: 25] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
Solid-phase organic synthesis is a powerful tool in the synthesis of small organic molecules and building of libraries of compounds for drug discovery. Heterocyclic compounds are important components of the drug discovery field as well and serve as a core for hundreds of marketed drugs. In particular, oxadiazole and thiadiazole cores are compounds of great interest due to their comprehensive biological activities and structural features. Therefore, a plethora of oxadiazole and thiadiazole synthesis methodologies have been reported to date, including solution and solid-phase synthesis methodologies. In this review, we concentrate on and summarize solid-phase synthetic approaches of the oxadiazole and thiadiazole derivatives.
Collapse
Affiliation(s)
- Aizhan Abdildinova
- Innovative Drug Library Research Center, Department of Chemistry, College of Science, Dongguk University, 26, 3-ga, Pil-dong, Jung-gu, Seoul 04620, Korea
| | - Young-Dae Gong
- Innovative Drug Library Research Center, Department of Chemistry, College of Science, Dongguk University, 26, 3-ga, Pil-dong, Jung-gu, Seoul 04620, Korea
| |
Collapse
|
4
|
Xu W, Ge Y, Hou Y, Liu Y, Hua Y, Han W, Qin Z, Liu F. Asymmetric Synthesis and Antitumor Activity of Spiro-Oxadiazole Derivatives from 1,4:3,6-Dianhydro- D
-fructose. CHINESE J CHEM 2017. [DOI: 10.1002/cjoc.201700058] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Wenke Xu
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of Henan New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
| | - Yongxun Ge
- Zhengzhou Central Hospital Affiliated to Zhengzhou University; Zhengzhou Henan 450007 China
| | - Yu Hou
- Department of Medicine; Kaifeng University; Kaifeng Henan 475000 China
| | - Yingju Liu
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of Henan New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
| | - Yingchun Hua
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of Henan New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
| | - Weiwei Han
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of Henan New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
| | - Zhiyan Qin
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
| | - Fengwu Liu
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of Henan New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
| |
Collapse
|
5
|
Kushwaha D, Tiwari VK. Click Inspired Synthesis of 1,2,3-Triazole-linked 1,3,4-Oxadiazole Glycoconjugates. J Heterocycl Chem 2017. [DOI: 10.1002/jhet.2845] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Divya Kushwaha
- Department of Chemistry, Institute of Science; Banaras Hindu University; Varanasi 221005 India
| | - Vinod K. Tiwari
- Department of Chemistry, Institute of Science; Banaras Hindu University; Varanasi 221005 India
| |
Collapse
|
6
|
Li P, Wang X, Li J, Meng ZY, Li SC, Li ZJ, Lu YY, Ren H, Lou YQ, Lu C, Dou GF, Zhang GL. Quantitative and qualitative analysis of the novel antitumor 1,3,4-oxadiazole derivative (GLB) and its metabolites using HPLC-UV and UPLC-QTOF-MS. Sci Rep 2015; 5:11906. [PMID: 26148672 PMCID: PMC4493701 DOI: 10.1038/srep11906] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2015] [Accepted: 06/03/2015] [Indexed: 12/30/2022] Open
Abstract
Fructose-based 3-acetyl-2,3-dihydro-1,3,4-oxadiazole (GLB) is a novel antitumor agent and belongs to glycosylated spiro-heterocyclic oxadiazole scaffold derivative. This research first reported a simple, specific, sensitive and stable high performance liquid chromatography-ultraviolet detector (HPLC-UV) method for the quantitative determination of GLB in plasma. In this method, the chromatographic separation was achieved with a reversed phase C18 column. The calibration curve for GLB was linear at 300 nm. The lower limit of quantification was 10 ng/mL. The precision, accuracy and stability of the method were validated adequately. This method was successfully applied to the pharmacokinetic study in rats for detection of GLB after oral administration. Moreover, the structures of parent compound GLB and its two major metabolites M1 and M2 were identified in plasma using an ultra performance liquid chromatography-electrospray ionization-quadrupole-time of flight- mass spectrometry (UPLC-ESI-QTOF-MS) method. Our results indicated that the di-hydroxylation (M1) and hydroxylation (M2) of GLB are the major metabolites. In conclusion, the present study provided valuable information on an analytical method for the determination of GLB and its metabolites in rats, can be used to support further developing of this antitumor agent.
Collapse
Affiliation(s)
- Pu Li
- Department of Pharmacology, School of Basic Medical Sciences, Peking University, Beijing, 100191, PR. China
| | - Xin Wang
- Department of Pharmacology, School of Basic Medical Sciences, Peking University, Beijing, 100191, PR. China
| | - Jian Li
- Laboratory of Hematological Pharmacology, Beijing Institute of Transfusion Medicine, Beijing 100850, PR China
| | - Zhi-Yun Meng
- Laboratory of Hematological Pharmacology, Beijing Institute of Transfusion Medicine, Beijing 100850, PR China
| | - Shu-Chun Li
- Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, PR. China
| | - Zhong-Jun Li
- Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, PR. China
| | - Ying-Yuan Lu
- Department of Pharmacology, School of Basic Medical Sciences, Peking University, Beijing, 100191, PR. China
| | - Hong Ren
- Department of Pharmacology, School of Basic Medical Sciences, Peking University, Beijing, 100191, PR. China
| | - Ya-Qing Lou
- Department of Pharmacology, School of Basic Medical Sciences, Peking University, Beijing, 100191, PR. China
| | - Chuang Lu
- Millennium Pharmaceuticals-Takeda, Cambridge, Massachusetts, USA
| | - Gui-Fang Dou
- Laboratory of Hematological Pharmacology, Beijing Institute of Transfusion Medicine, Beijing 100850, PR China
| | - Guo-Liang Zhang
- Department of Pharmacology, School of Basic Medical Sciences, Peking University, Beijing, 100191, PR. China
| |
Collapse
|
7
|
He YW, Cao LH, Zhang JB, Wang DZ, Aisa HA. Synthesis and bioactivity of 5-(1-aryl-1H-tetrazol-5-ylsulfanylmethyl)-N-xylopyranosyl-1,3,4-oxa(thia)diazol-2-amines. Carbohydr Res 2011; 346:551-9. [PMID: 21353206 DOI: 10.1016/j.carres.2011.01.010] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2010] [Revised: 01/10/2011] [Accepted: 01/11/2011] [Indexed: 11/29/2022]
Abstract
A series of new N'-[N-(2,3,4-tri-O-acetyl-β-d-xylopyranosyl)thiocarbamoyl]-2-[(1-aryl-1H-tetrazol-5-yl)sulfanyl]acetohydrazides 5a-5e were synthesized rapidly in high yields from 2-(1-aryl-1H-tetrazol-5-ylsulfanyl)acetohydrazides 3a-3e and 2,3,4-tri-O-acetyl-β-d-xylopyranosyl isothiocyanate 4, then 5a-5e were converted to a series of new 5-(1-aryl-1H-tetrazol-5-ylsulfanylmethyl)-N-(2,3,4-tri-O-acetyl-β-D-xylopyranosyl)-1,3,4-oxadiazole-2-amines 6a-6e and 5-(1-aryl-1H-tetrazol-5-ylsulfanylmethyl)-N-(2,3,4-tri-O-acetyl-β-D-xylopyranosyl)-1,3,4-thiadiazole-2-amines 7a-7e, respectively under mercuric acetate/alcohol system or acetic anhydride/phosphoric acid system, then deacetylated in the solution of CH(3)ONa/CH(3)OH. All of the novel compounds were characterized by IR, (1)H NMR, (13)C NMR, MS and elemental analysis. The structures of compounds 2e, 3e, 5a and 5c have been determined by X-ray diffraction analysis. Some of the synthesized compounds displayed PTP1B inhibition and microorganism inhibition.
Collapse
Affiliation(s)
- Yao-Wu He
- Key Laboratory of Chemistry of Plant Resources in Arid Regions, Chinese Academy of Sciences, Xinjiang Technical Institute of Physics and Chemistry, Urumqi 830011, PR China
| | | | | | | | | |
Collapse
|